Results: During the study period, 769 infrarenal AAA repairs were performed at our institution; 675 repairs fit the inclusion criteria (315 OR and 360 EVARs). Mean age was 73.9 years, 79% were males, 78% were hypertensive, 18% were diabetic, and 31% had preoperative renal dysfunction defined as a GFR <60 mL/min. A multivariate logistic model to control for all variables found that OR had a 1.6-times greater chance of developing immediate postoperative AKI compared with EVAR (P ¼ .038). Hypertension and aneurysm size were also independent risk factors for developing AKI (P ¼ .012 and P ¼ .022, respectively). Using a linear regression model, we found a greater decline in GFR postoperatively in the EVAR group. This was significant starting at postoperative year 4 (Fig) . AKI and preoperative renal dysfunction were other independent risk factors for long-term decline in renal function.
VESS24.

Duplex Ultrasound Assessment and Outcomes of Renal Malperfusion Syndromes After Acute Aortic Dissection
Michael J. Osgood, Joshua Grimm, Christopher J. Abularrage, Ying Wei Lum, Diana Call, James H. Black III. Johns Hopkins Hospital, Baltimore, Md
Objectives: Acute aortic dissection involving the renovisceral aorta may result in renal malperfusion. A lack of consensus exists regarding the management of renal malperfusion syndromes. We therefore sought to characterize the natural history of renal malperfusion in acute aortic dissection, identify ultrasound features predictive of renal failure, and assess the long-term result of malperfusion procedures.
Methods: Using institutional databases, we identified patients presenting with acute Stanford type A and B aortic dissections with involvement of the renovisceral aorta between 2004 and 2016. We collected demographics, radiographic data, including computed tomography and renal duplex scans, creatinine (Cr) levels, and clinical outcomes. Primary outcomes were overall mortality, progression to acute kidney injury (AKI; defined as increase in serum Cr of >50%), and peak and follow-up Cr levels. We further assessed the outcomes in patients who underwent a procedure to treat malperfusion (thoracic endovascular aortic repair, renal artery stenting, central aortic fenestration).
Results:
We identified 38 patients with acute dissection involving the renovisceral aorta. Mean follow-up was 5.8 years, mean age was 58.2, 74% were male, 45% had Stanford type A, and 55% had Stanford type B dissections. The true lumen supplied both renal arteries in 21%, the false lumen supplied both renal arteries in 8%, and the remaining 71% of patients had one renal artery supplied by each lumen. AKI developed in 71% of patients, 10.5% required dialysis, and 5% developed permanent dialysis dependence. Mean Cr at presentation was 1.6 mg/dL, mean peak Cr was 3.6, and mean follow-up Cr was 1.8. Development of AKI was correlated with higher peak initial Cr levels (4.2 vs 2.2; P ¼ .02) and higher mortality (22% vs 0%; P ¼ .04). Progression to AKI was associated with significantly lower end-diastolic velocity (EDV) measurements on renal duplex (17 vs 28 cm/s; P ¼ .01); however, peak systolic velocities (PSV) were not predictive. In follow-up, no kidneys developed atrophy when EDV was >30 cm/s. Intervention (10 of 38) was associated with lower follow-up Cr (0.88 vs 2.12; P ¼ .02), although there was no difference in progression to AKI, dialysis dependence, or mortality.
Conclusions: Development of AKI following acute aortic dissection of the visceral abdominal aorta is associated with higher mortality. Performing a renal malperfusion procedure did not significantly improve renal outcomes or overall survival, although the follow-up Cr in this group was lower. Renal malperfusion syndromes can be accurately predicted by EDV measurements on renal duplex ultrasound imaging.
Author Disclosures: C. J. Abularrage: Nothing to disclose; J. H. Black: Nothing to disclose; D. Call: Nothing to disclose; J. Grimm: Nothing to disclose; Y. Lum: Nothing to disclose; M. J. Osgood: Nothing to disclose. Objectives: Prior aortic surgery is a risk factor for increased morbidity following subsequent open aortic surgery. The purpose of this study was to evaluate the impact of prior aortic surgery on outcomes after subsequent multibranched endovascular repair (MBEVAR) of thoracoabdominal (TAAA) and pararenal aortic aneurysms (PRAA).
VESS25. The Impact of Prior Aortic Surgery on Outcomes After Multibranched Endovascular Repair of Thoracoabdominal and Pararenal Aortic Aneurysms
Methods: From July 2005 to October 2016, 153 patients underwent elective endovascular repair of TAAA and PRAA using multibranched stent grafts. Data on demographics, operative repair, complications, and outcomes were collected prospectively.
Results: The mean age was 73 6 8 years, and 113 of 153 (74%) were men. Mean aneurysm diameter was 67 6 9 mm. Of 153 patients, 72 (47%) had undergone a prior aortic surgery before MBEVAR, 53 (74%) had prior open aortic surgery, 14 (19%) had prior endovascular aortic surgery, and 5 (7%) had both. There were no significant differences in age, sex, preoperative aneurysm diameter, or medical comorbidities (coronary artery disease, lung disease, diabetes mellitus, or hypertension) in patients who had previous aortic surgery compared to those without previous aortic surgery. Compared to those without previous aortic surgery, patients with previous aortic surgery had longer fluoroscopy times (116 6 51 vs 133 6 61 minutes; P ¼ .07) and procedural times (340 6 110 vs 375 6 110 minutes; P ¼ .12) during MBEVAR, but these did not reach statistical significance. Postoperative paraplegia developed in 12 of 153 patients (8%); this occurred in 3 of 72 of patients (4%) with previous aortic surgery compared to 9 of 81 (11%) without previous aortic surgery (P ¼ .14). Three of 153 patients (2%) had a postoperative stroke, and this was not different between the two groups. Median follow-up time was 3.0 years (interquartile range, 1.0-4.5 years) and did not differ between those with and without previous aortic surgery. Kaplan-Meier estimated 5-year freedom from aneurysmrelated mortality and overall mortality was 90% and 48%, respectively, and did not differ between the two groups (Fig 1, A and B) . There was also no difference in branch vessel occlusion or reintervention rates between the two groups. 
VESS26. Presence and Degree of Residual Venous Obstruction on Serial Duplex Imaging Increases the Risk of Recurrence and Progression of Lower Extremity Deep Venous Thrombosis
Taehwan Yoo, Rishav Aggarwal, Tzu-Fei Wang, Bhagwan Satiani, Mounir Haurani. Ohio State University, Columbus, Ohio
Objectives: The role of follow-up venous duplex ultrasound (DUS) imaging after acute lower extremity deep vein thrombosis (DVT) remains unclear, yet it is commonly performed. Our primary objective was to determine the association between the presence of residual venous obstruction (RVO) and DVT recurrence or propagation (rDVT). Secondary objectives included finding risk factors associated with RVO and the role of follow-up DUS imaging.
Methods:
We conducted a retrospective study of patients diagnosed with DVT by DUS imaging at our institution from 2011 to 2013 who received a follow-up study. Patient demographics, risk factors, medications, and DUS findings were recorded. Ten segments from the common femoral to distal calf veins were checked for presence of RVO, DVT propagation, and recurrence. RVO was defined as any nonacute venous obstruction with >40% of the luminal diameter remaining during compression or presence of chronic thrombus. rDVT was measured as a new acute DVT in the same previously involved segment or involvement of a new segment in the same extremity.
Results: A total of 199 lower extremities representing 182 patients met the inclusion criteria. RVO was noted in 53.2%. Mean (standard error of the mean) DUS follow-up was 254.2 6 23 days. rDVT rate was 16.4%. Patients with previous venous thromboembolism or thrombophilia had a higher risk of developing RVO (RR ¼ 1.5, P ¼ .003; RR ¼ 1.6, P ¼ .02, respectively). Extremities with initial clot burden of three or more segments had an increased risk of RVO on follow-up DUS (RR ¼ 1.4; P ¼ .02). A total of 74 extremities had multiple serial DUS, representing 72 patients. Extremities in this subgroup with presence of RVO on the first follow-up DUS had increased risk of rDVT on subsequent DUS (RR ¼ 6.4; P < .001). RVO in three or more segments also predicted rDVT (RR ¼ 2.25; P ¼ .04).
Conclusions: Extremities with larger initial clot burden increased the risk of subsequent RVO. The presence of RVO, as well as the number of involved segments on follow-up DUS, increased the risk of rDVT. Our results suggest that follow-up DUS after acute DVT may identify patients with presence of RVO and increased RVO burden who are at increased risk for rDVT and may help guide the duration of anticoagulation therapy.
Author Disclosures: R. Aggarwal: Nothing to disclose; M. Haurani: Nothing to disclose; B. Satiani: Nothing to disclose; T. Wang: Nothing to disclose; T. Yoo: Nothing to disclose.
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Alternative Objectives: Dialysis access in the obese is a common problem. The VWING device (Vital Access, Salt Lake City, Utah) is a novel technology facilitating difficult or deep cannulation when the fistula is 4 to 13 mm deep. One or two devices can be surgically placed on the fistula after maturation as needle guides to allow fistula access while avoiding transposition. This data set illustrates real-world use of the device.
Methods: Data were obtained from a retrospective review of a prospective database maintained by Vital Access, tracking devices implanted from May 1, 2012, to November 1, 2016. All patients with at least 30 days' follow-up or death within 30 days were included in the analysis. The c 2 test and multivariable regression in Stata (StataCorp LP, College Station, Tex) were used for analysis.
Results: Included were 655 patients. Six deaths within 30 days (0.9%) were not thought to be due to devices. Average follow-up time was 337 days (range, 9-1464 days). Accesses modified by VWING were brachiocephalic, 64.8%; brachiobasilic, 16.2%; radiocephalic, 13.2%; previously transposed fistula, 4.3%; and graft, 1.3%. Average time to first sharp cannulation after implantation was 68 days (median, 48 days). Time to blunt cannulation averaged 75 days (median, 59 days). Average duration of VWING use at last follow-up was 203 days (range, 0-1200 days). When catheter removal was documented, it occurred an average of 116 days (median, 95 days) after VWING implantation. A total of 353 patients (53.2%) were using at least one device at last follow-up. Percent VWINGS in use by year of implantation were 2013, 38%; 2014, 43%; 2015, 53%; and 2016, 65% . Reasons VWINGs were not used in 306 patients included 36% cannulation problems, 27.5% fistula failure, 10.4% predialysis, 7.8% another modality used, 5.5% patient refusal, 3.9% flow issues, and 2% infection. Surgeons who had placed devices in more than one patient were more 
